NYSE:TFXMedical Equipment
Teleflex Split And BIOTRONIK Deal Reframe Growth And Risk Profile
Teleflex (NYSE:TFX) plans to separate into two independent publicly traded companies, RemainCo and NewCo, with completion targeted for mid-2026.
The separation is expected to reshape Teleflex's business focus, capital allocation, and risk profile across the two entities.
Teleflex also announced the acquisition of BIOTRONIK Vascular Intervention's business, expanding its cath lab market presence and product lineup.
Teleflex operates across a range of medical technologies, and these moves...